This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Idac Theranostics, Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Takayoshi Shirasaki: Innovator in Antiviral Drug Development
Introduction
Takayoshi Shirasaki is a notable inventor based in Kanazawa, Japan. He has made significant contributions to the field of antiviral drug development. His innovative work focuses on suppressing the expression of target genes related to viral infections.
Latest Patents
Shirasaki holds a patent for an antiviral drug that comprises an active ingredient capable of suppressing the expression of a target gene or the activity of a protein encoded by that gene. The target genes identified in his patent include DOCK11, LIPG, DENND2A, and HECW2, which are involved in retaining virus-derived nucleic acids in host cells. This invention also includes a screening method for the antiviral drug.
Career Highlights
Shirasaki is currently associated with Idac Theranostics, Inc., where he continues to advance his research in antiviral therapies. His work has the potential to impact the treatment of viral infections significantly.
Collaborations
Some of his notable coworkers include Shin-ichi Hashimoto and Shuichi Kaneko, who contribute to the collaborative efforts in research and development at Idac Theranostics.
Conclusion
Takayoshi Shirasaki's innovative approach to antiviral drug development showcases his commitment to addressing viral infections through scientific research. His contributions are paving the way for new therapeutic options in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile